申请人:Bayer Pharma Aktiengesellschaft
公开号:US20170020886A1
公开(公告)日:2017-01-26
The present invention relates to amido-substituted azole compounds of general formula (I), in which X
1
, X
2
, R
1
, R
2
, R
4
, R
5
, R
7
and R
8
are as defined in the claims which are inhibitors of TNKS1 and/or TNKS2, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.